Retigabine
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Retigabine Product Information
Retigabine is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Retigabine. The product is supplied by Clearsynth under CAT No. CS-O-02282.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Retigabine
CAS No.
150812-12-7
CAT No.
CS-O-02282
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C16H18FN3O2
Molecular Weight
303.33
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Retigabine is supplied with detailed characterization data compliant with regulatory guideline. Retigabine can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Retigabine.
Overview
Retigabine is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive
Synonyms
Retigabine
Application Notes
Retigabine is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.